Loading...

Abbott Laboratories (NYSE:ABT)

109.45 USD +3.24 USD ( +3.05% )
Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist

Relative Value

The Relative Value of one ABT stock under the Base Case scenario is 118.84 USD. Compared to the current market price of 109.45 USD, Abbott Laboratories is Undervalued by 8%.

Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

ABT Relative Value
Base Case
118.84 USD
Undervaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

Median 5
Industry 2.4
Forward Multiple 4.6
Median 40.3
Industry 18.5
Forward Multiple 22.4
Median 24
Industry 12.7
Forward Multiple N/A
Median 36.3
Industry 14.3
Forward Multiple N/A
Median 5.8
Industry 2.4
Forward Multiple N/A
Median 25.5
Industry 12.8
Forward Multiple N/A
Median 3.3
Industry 2.2
Forward Multiple N/A

Multiples Across Competitors

ABT Competitors Multiples
Abbott Laboratories Competitors

Country Company Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbott Laboratories
NYSE:ABT
193B USD 4.3 25 15.4 21.2
IE
Medtronic PLC
NYSE:MDT
120B USD 3.8 23.8 13.5 18.7
US
Stryker Corp
NYSE:SYK
77.3B USD 4.4 38.4 20.8 26.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
75.3B USD 12.8 45.8 31.2 36.9
US
Becton Dickinson and Co
NYSE:BDX
71.5B USD 3.6 37.2 17 30.9
US
Edwards Lifesciences Corp
NYSE:EW
60.3B USD 11.2 39.2 31.2 33.6

See Also

Similar Stocks